Evidence map›Paper›PMID 34676056›Full record

ArticleOncotarget2021

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201.

Joshua E Allen, C Leah B Kline, Varun V Prabhu, Jessica Wagner, Jo Ishizawa, Neel Madhukar, Avital Lev, Marie Baumeister, Lanlan Zhou, Amriti Lulla and 22 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Mitochondrial Protease ClpP: Cancer Marker and Drug Target.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Joshua E AllenOncoceutics, Inc., Philadelphia, PA, USA.
C Leah B KlineFox Chase Cancer Center, Philadelphia, PA, USA.
Varun V PrabhuOncoceutics, Inc., Philadelphia, PA, USA.
Jessica WagnerFox Chase Cancer Center, Philadelphia, PA, USA.
Jo IshizawaUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Neel MadhukarWeill Cornell Medicine, New York, NY, USA.
Avital LevFox Chase Cancer Center, Philadelphia, PA, USA.
Marie BaumeisterFox Chase Cancer Center, Philadelphia, PA, USA.
Lanlan ZhouFox Chase Cancer Center, Philadelphia, PA, USA.
Amriti LullaFox Chase Cancer Center, Philadelphia, PA, USA.
Martin StogniewOncoceutics, Inc., Philadelphia, PA, USA.
Lee SchalopOncoceutics, Inc., Philadelphia, PA, USA.
Cyril BenesMassachusetts General Hospital, Boston, MA, USA.
Howard L KaufmanRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Richard S PottorfProvid Pharmaceuticals, Monmouth Junction, NJ, USA.
B Rao NallaganchuProvid Pharmaceuticals, Monmouth Junction, NJ, USA.
Gary L OlsonProvid Pharmaceuticals, Monmouth Junction, NJ, USA.
Fahd Al-MullaKuwait University Medical School, Kuwait.
Madeleine DuvicUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gen Sheng WuKarmanos Cancer Institute, Detroit, MI, USA.
David T DickerFox Chase Cancer Center, Philadelphia, PA, USA.
Mala K TalekarThe Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Bora LimUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Olivier ElementoWeill Cornell Medicine, New York, NY, USA.
Wolfgang OsterOncoceutics, Inc., Philadelphia, PA, USA.
Joseph BertinoRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Keith FlahertyMassachusetts General Hospital, Boston, MA, USA.
Michael L WangUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gautam BorthakurUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michael AndreeffUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mark SteinRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Wafik S El-DeiryFox Chase Cancer Center, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.11814.].

Identifiers

PMID34676056
PMCPMC8522842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.